4-Hydroxyoxyphenbutazone exhibits potent activity against both replicating and non-replicating (NR) Mycobacterium tuberculosis (Mtb), including drug-resistant strains; it is a potent inhibitor of cytokine production and an immunosuppressive agent with potential for research in rheumatoid arthritis.